🇺🇸 US

CRL revenue, net income and debt history (Charles River Laboratories International, Inc.)

Quick answer

Charles River Laboratories International, Inc. (CRL) reported revenue of $4.02B and net loss of $144.3M for the fiscal year ended 2025-12-27, down 0.9% from $4.05B the year before, per its 10-K filed with the SEC on 2026-02-18.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2025-12-27. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Fiscal yearRevenueNet incomeLong-term debt
2025 (FY ending 2025-12-27)$4.02B-$144.3M—
2024 (FY ending 2024-12-28)$4.05B$22.2M—
2023 (FY ending 2023-12-30)$4.13B$474.6M—
2022 (FY ending 2022-12-31)$3.98B$486.2M—
2021 (FY ending 2021-12-25)$3.54B$391.0M—
2020 (FY ending 2020-12-26)$2.92B$364.3M—
2019 (FY ending 2019-12-28)$2.62B$252.0M—
2018 (FY ending 2018-12-29)$2.27B$226.4M$1.61B
2017 (FY ending 2017-12-30)$1.86B$123.4M$1.09B
2016 (FY ending 2016-12-31)$1.68B$154.8M$1.18B

Related

Last updated 2026-10-16. Data only, not financial or tax advice.